Phase II study of 4-epirubicin, etoposide and cisplatin as neoadjuvant chemotherapy in locally advanced breast cancer

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Weekly paclitaxel and cisplatin as neoadjuvant chemotherapy with locally advanced breast cancer: a prospective, single arm, phase II study

Oncotarget ◽

10.18632/oncotarget.17954 ◽

2017 ◽

Vol 8 (45) ◽

pp. 79305-79314 ◽

Cited By ~ 12

Author(s):

Liheng Zhou ◽

Shuguang Xu ◽

Wenjin Yin ◽

Yanpin Lin ◽

Yueyao Du ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Advanced Breast ◽

Weekly Paclitaxel

Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-010-1401-2 ◽

2010 ◽

Vol 67 (6) ◽

pp. 1257-1263 ◽

Cited By ~ 5

Author(s):

Yen-Shen Lu ◽

Dar-Ren Chen ◽

Ling-Min Tseng ◽

Dah-Cherng Yeh ◽

Shou-Tung Chen ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Phase II study of dose-dense doxorubicin and docetaxel as neoadjuvant chemotherapy with G-CSF support in patients with large or locally advanced breast cancer

Clinical & Translational Oncology ◽

10.1007/s12094-008-0280-z ◽

2008 ◽

Vol 10 (11) ◽

pp. 739-744 ◽

Cited By ~ 2

Author(s):

Jesús García-Mata ◽

Andrés García-Palomo ◽

Lourdes Calvo ◽

Ramón Mel ◽

Juan Jesús Cruz ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Advanced Breast ◽

Dose Dense

A Phase II Study of Second-Line Neoadjuvant Chemotherapy With Capecitabine and Radiation Therapy for Anthracycline-Resistant Locally Advanced Breast Cancer

American Journal of Clinical Oncology ◽

10.1097/01.coc.0000245475.41324.6d ◽

2007 ◽

Vol 30 (1) ◽

pp. 78-81 ◽

Cited By ~ 22

Author(s):

Maria de F??tima Dias Gaui ◽

Gilberto Amorim ◽

Roberto Alfonso Arcuri ◽

Guilherme Pereira ◽

Denise Moreira ◽

...

Keyword(s):

Breast Cancer ◽

Radiation Therapy ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Advanced Breast ◽

Second Line

433 PUBLICATION A phase II study of neoadjuvant chemotherapy (NC) with taxotere, adriamycin and cyclophosphamide (TAC) in locally advanced breast cancer (LABC)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(05)80731-1 ◽

2005 ◽

Vol 3 (2) ◽

pp. 122

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Phase II study of combined docetaxel, epirubicin, and cyclophosphamide as a neoadjuvant chemotherapy regimen in patients with locally advanced breast cancer in a single institution.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.e11040 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. e11040-e11040

Author(s):

X. Yao ◽

J. R. Hosenpud ◽

C. R. Chitambar ◽

J. A. Charlson ◽

Y. Cheng

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Chemotherapy Regimen ◽

Phase Ii Study ◽

Locally Advanced ◽

Advanced Breast ◽

Single Institution

A Phase II Study of Concurrent Docetaxel, Epirubicin and Cyclophosphamide as a Neoadjuvant Chemotherapy Regimen in Patients with Locally Advanced Breast Cancer

Journal of Cancer ◽

10.7150/jca.3980 ◽

2012 ◽

Vol 3 ◽

pp. 145-151 ◽

Cited By ~ 8

Author(s):

Xin Yao ◽

Janet Hosenpud ◽

Christopher R. Chitambar ◽

John Charlson ◽

Yee Chung Cheng

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Chemotherapy Regimen ◽

Phase Ii Study ◽

Locally Advanced ◽

Gemcitabine/Epirubicin/Paclitaxel as Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group

Clinical Breast Cancer ◽

10.3816/cbc.2008.n.029 ◽

2008 ◽

Vol 8 (3) ◽

pp. 257-263 ◽

Cited By ~ 6

Author(s):

John T. Hamm ◽

John W. Wilson ◽

Priya Rastogi ◽

Barry C. Lembersky ◽

George C. Tseng ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Research Group ◽

Phase Ii Trial ◽

Locally Advanced ◽

OT2-01-03: Eribulin in Women with Locally Advanced Breast Cancer Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy: A Sarah Cannon Research Institute Phase II Trial.

10.1158/0008-5472.sabcs11-ot2-01-03 ◽

2011 ◽

Author(s):

DA Yardley ◽

NW Peacock ◽

JD Hainsworth ◽

III HA Burris

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Pathologic Complete Response ◽

Complete Response ◽

225P Phase II study of pyrotinib plus albumin-bound paclitaxel and trastuzumab as neoadjuvant treatment in HER2-positive early or locally advanced breast cancer

Annals of Oncology ◽

10.1016/j.annonc.2020.08.346 ◽

2020 ◽

Vol 31 ◽

pp. S331

Author(s):

T. Luo ◽

X. Zhong ◽

P. He ◽

X. Yan ◽

T. Tian ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Neoadjuvant Treatment ◽

Advanced Breast ◽

Her2 Positive